New furano- and pyrrolo[2,3-d]pyrimidine nucleosides and their 5′-O-triphosphates: Synthesis and biological properties

Bicyclic furano[2,3- d ]pyrimidine ribonucleosides were synthesized by Pd(0)-and CuI-catalyzed coupling of 5-iodouridine with terminal alkynes. The treatment of the resulting nucleosides with ammonia or methylamine solution in aqueous alcohol resulted in pyrrolo-and N 7 -methylpyrrolo[2,3- d ]pyrimi...

Full description

Saved in:
Bibliographic Details
Published in:Russian journal of bioorganic chemistry Vol. 34; no. 5; pp. 593 - 601
Main Authors: Ivanov, M. A., Ivanov, A. V., Krasnitskaya, I. A., Smirnova, O. A., Karpenko, I. L., Belanov, E. F., Prasolov, V. S., Tunitskaya, V. L., Alexandrova, L. A.
Format: Journal Article
Language:English
Published: Dordrecht SP MAIK Nauka/Interperiodica 2008
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bicyclic furano[2,3- d ]pyrimidine ribonucleosides were synthesized by Pd(0)-and CuI-catalyzed coupling of 5-iodouridine with terminal alkynes. The treatment of the resulting nucleosides with ammonia or methylamine solution in aqueous alcohol resulted in pyrrolo-and N 7 -methylpyrrolo[2,3- d ]pyrimidine nucleosides. 5′- O -Triphosphates of bicyclic nucleosides were obtained by the treatment of the nucleosides with POCl 3 in the presence of a “proton sponge.” The 5′- O -triphosphates are not substrates for HCV RNA-dependent RNA polymerase, but are effective substrates for HCV RNA helicase/NTPase and did not inhibit ATP hydrolysis. Only 3-(β- D -ribofuranosyl)-6-decyl-2,3-dihydrofuro-[2,3- d ]pyrimidin-2-one showed a moderate anti-HCV activity in the HCV replicon system and efficiently inhibited replication of bovine viral diarrhea virus (BVDV) in KCT-cells, other compounds being inactive. None of the compounds were cytotoxic within the tested range of concentrations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1068-1620
1608-330X
DOI:10.1134/S1068162008050099